The Journal of Immunology, Vol 158, Issue 2 685-692, Copyright © 1997 by American Association of Immunologists

ARTICLES

Presentation of an influenza nucleoprotein epitope incorporated into the H-2Db signal sequence requires the transporter-associated with antigen presentation

RA Uger and BH Barber
Department of Immunology, Medical Sciences Building, University of Toronto, Canada.

In an effort to optimize the formation of peptide-specific CTL target structures in the context of plasmid DNA immunization, a strategy was developed to couple the biosynthesis of a class I heavy chain with its optimal binding epitope. Specifically, a cDNA expression vector was constructed with the influenza nucleoprotein epitope NP366-74 incorporated into the signal sequence of its restriction element H-2Db. Transporter associated with Ag presentation-expressing murine cell lines P815 (H-2d) and BW5147 (H-2k) transfected with this modified heavy chain expressed normal levels of plasmid-encoded Db at the cell surface, and were lysed by NP366-74-specific CTL. These results indicate that the modified signal sequence was successfully delivered to the endoplasmic reticulum, and the epitope within it processed for T cell recognition. In contrast, T2 cells, which lack the TAP transporter, when transfected with the same vector were not lysed by NP366-74 CTL, and exhibited an Ag-processing-defective phenotype. Thus, these data, which indicate TAP-dependent presentation of an optimal CTL epitope located in a signal sequence, challenge the effectiveness of Ag processing in the endoplasmic reticulum.

This article has been cited by other articles:

				L. Wei, M. R. Sandbulte, P. G. Thomas, R. J. Webby, R. Homayouni, and L. M. Pfeffer NF{kappa}B Negatively Regulates Interferon-induced Gene Expression and Anti-influenza Activity J. Biol. Chem., April 28, 2006; 281(17): 11678 - 11684. [Abstract] [Full Text] [PDF]

				A. Bai, C. J. Aldrich, and J. Forman Factors Controlling the Trafficking and Processing of a Leader-Derived Peptide Presented by Qa-1 J. Immunol., December 15, 2000; 165(12): 7025 - 7034. [Abstract] [Full Text] [PDF]

				C. S. Dela Cruz, R. Tan, S. L. Rowland-Jones, and B. H. Barber Creating HIV-1 reverse transcriptase cytotoxic T lymphocyte target structures by HLA-A2 heavy chain modifications Int. Immunol., September 1, 2000; 12(9): 1293 - 1302. [Abstract] [Full Text] [PDF]

				R. A. Uger, S. M. Chan, and B. H. Barber Covalent Linkage to {beta}2-Microglobulin Enhances the MHC Stability and Antigenicity of Suboptimal CTL Epitopes J. Immunol., May 15, 1999; 162(10): 6024 - 6028. [Abstract] [Full Text] [PDF]

				G. Y. Ishioka, J. Fikes, G. Hermanson, B. Livingston, C. Crimi, M. Qin, M. France del Guercio, C. Oseroff, C. Dahlberg, J. Alexander, et al. Utilization of MHC Class I Transgenic Mice for Development of Minigene DNA Vaccines Encoding Multiple HLA-Restricted CTL Epitopes J. Immunol., April 1, 1999; 162(7): 3915 - 3925. [Abstract] [Full Text] [PDF]